Abstract
References
Abstract: P523
Title: THE COMPARISON OF VFLAI, FLAI AND 3+7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD
Abstract Type: Poster Presentation
Keywords: Outcome | Acute myeloid leukemia | Venetoclax | Clinical trial
Title: THE COMPARISON OF VFLAI, FLAI AND 3+7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD
Abstract Type: Poster Presentation
Keywords: Outcome | Acute myeloid leukemia | Venetoclax | Clinical trial
This abstract is embargoed until Friday, June 9, 2023 (09:00 CEST)
Presentation during EHA2023: All (e)Poster presentations will be made available as of Friday, June 9, 2023 (09:00 CEST) and will be accessible for on-demand viewing until Tuesday, August 15, 2023 on the Congress platform.
Abstract: P523
Title: THE COMPARISON OF VFLAI, FLAI AND 3+7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD
Abstract Type: Poster Presentation
Keywords: Outcome | Acute myeloid leukemia | Venetoclax | Clinical trial
Presentation during EHA2023: All (e)Poster presentations will be made available as of Friday, June 9, 2023 (09:00 CEST) and will be accessible for on-demand viewing until Tuesday, August 15, 2023 on the Congress platform.
Abstract: P523
Title: THE COMPARISON OF VFLAI, FLAI AND 3+7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD
Abstract Type: Poster Presentation
Keywords: Outcome | Acute myeloid leukemia | Venetoclax | Clinical trial
This abstract is embargoed until Friday, June 9, 2023 (09:00 CEST)
Presentation during EHA2023: All (e)Poster presentations will be made available as of Friday, June 9, 2023 (09:00 CEST) and will be accessible for on-demand viewing until Tuesday, August 15, 2023 on the Congress platform.
Abstract: P523
Title: THE COMPARISON OF VFLAI, FLAI AND 3+7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD
Abstract Type: Poster Presentation
Keywords: Outcome | Acute myeloid leukemia | Venetoclax | Clinical trial
Presentation during EHA2023: All (e)Poster presentations will be made available as of Friday, June 9, 2023 (09:00 CEST) and will be accessible for on-demand viewing until Tuesday, August 15, 2023 on the Congress platform.
Abstract: P523
Title: THE COMPARISON OF VFLAI, FLAI AND 3+7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD
Abstract Type: Poster Presentation
Keywords: Outcome | Acute myeloid leukemia | Venetoclax | Clinical trial
{{ help_message }}
{{filter}}